Veradermics Incorporated announced positive topline results from Part B of its Phase 2/3 clinical trial for VDPHL01, an oral extended-release minoxidil treatment for male pattern hair loss, Fierce Pharma reported. Phase 2/3 Trial Results The trial, known as Study 302, evaluated 519 male participants with mild-to-moderate hair loss over 12 months. Patients receiving a twice-daily … Read more
Liquidia will pay United Therapeutics $380.7 million to settle six ongoing lawsuits, bringing an end to a yearslong patent dispute between the two drugmakers. As part of the agreement, Liquidia will make net payments in multiple installments through 2027 and remove one of its core drug indications from the market. Federal Court Ruling Over Treprostinil … Read more
The National Pharmaceutical Pricing Authority (NPPA) has restricted trade margins on non-scheduled anti-cancer medicines to 30% to lower patient costs. This measure is expected to reduce the maximum retail price (MRP) of some expensive cancer drugs by up to 70%, potentially saving patients approximately Rs 2,500 crore annually, according to central government estimates. 30% Trade … Read more